http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102267370-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-495 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-495 |
| filingDate | 2019-11-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2021-06-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2021-06-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-102267370-B1 |
| titleOfInvention | Improvement agents for cytokine release syndrome, etc. |
| abstract | (Project) Provision of a medicament for cytokine release syndrome, autoimmune disease-related side effects, macrophage activation syndrome, hemophagocytic lymphohistiocytosis, or Langerhans cell histiocytosis. (Solution Means) Cytokine release syndrome, autoimmune disease-related side effects, macrophage activation syndrome, hemophagocytic lymphohistiocytosis and Langerhans cell histiocytosis, containing a compound represented by the following formula I: or a pharmaceutically acceptable salt thereof A drug for at least one selected from the group consisting of.] |
| priorityDate | 2018-11-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 604.